The price of some medicines in Nigeria has risen almost tenfold in the past ten months, forcing patients to cut doses or turn to traditional alternatives. According to Reuters, pharmaceutical industry officials said the plunge in the value of the naira after the removal of currency controls in June has sent prices of new stocks rocketing. The departure of British drug maker GlaxoSmithKline after increased local competition and from imports from India and China also added to the woes.